AI-Personalized Skincare Regimen for Facial Photoaging in Women
Public ClinicalTrials.gov record NCT07879833. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Clinical Study to Assess the Efficacy of a Customized Skincare Regimen on Women Exhibiting Signs of Skin Aging
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this clinical study was to learn whether a skincare regimen personalized by an artificial intelligence (AI) skin-analysis tool improves signs of facial skin aging in women aged 35 to 65 with mild-to-moderate facial photoaging. The main questions it aimed to answer were: Does the personalized regimen improve fine lines, wrinkles, firmness, smoothness, tone and other signs of skin aging after 4 and 12 weeks of use? Is the regimen well tolerated? Participants completed an online skin questionnaire and uploaded a facial selfie, and the AI tool assigned one of three night creams. Each participant then used a personalized kit at home for 12 weeks: a vitamin C serum and SPF 30 sunscreen in the morning; the assigned night cream (0.3% retinol, 0.6% retinol, or bakuchiol, each with a triple-peptide complex), an eye cream, and a dark spot remover in the evening; and a daily oral marine collagen supplement. Participants visited the clinic at baseline, week 4 and week 12 for expert skin grading, skin measurements, photographs and questionnaires.
Study identification
- NCT ID
- NCT07879833
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 43 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 35 Years to 65 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2025 (Actual)
- Primary completion
- Feb 13, 2026 (Actual)
- Completion
- Feb 13, 2026 (Actual)
- Last update posted
- Oct 19, 2026
2025 – 2026
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| SGS North America Inc., Clinical Research | Richardson | Texas | 75081 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07879833, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 19, 2026 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07879833 live on ClinicalTrials.gov.